[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:fviii-inhibitor":3},{"name":4,"total":5,"recruiting":5,"trials":6},"FVIII inhibitor",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07416604","A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A",[11],"Phase 3","RECRUITING","2026-08-26T02:18:38.865010Z","2026-05-13T02:55:06.702455Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05987449","A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",[19],"Phase 1\u002FPhase 2","2026-08-26T02:17:39.048487Z","2026-05-05T02:43:26.727335Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT04023019","Treatment of Hemophilia A Patients With FVIII Inhibitors",[],"2026-08-26T02:18:17.950264Z","2026-05-13T02:55:06.182752Z"]